This week’s guest is Tom Logan, the CEO of Mirion Technologies (Ticker: MIR). Mirion was founded in 2005 and Tom has been the company’s only CEO over that period of time. Mirion is a global leader in radiation measurement, serving end markets such as nuclear, life sciences, healthcare and industrial. Mirion recently became publicly traded via a SPAC, but unlike many other de-SPACed companies, Mirion has a long operating history and generates positive EBITDA. The company has had to weather a number of headwinds over Tom’s tenure, including the Global Financial Crisis, the Fukushima nuclear disaster in Japan, and of course COVID. Despite that, the company has grown consistently through organic and inorganic means and expanded its margins meaningfully. With all of that as a backdrop, I was excited to talk to Tom about:
- The current state of the base of nuclear power plants around the world and how the Russia-Ukraine conflict is impacting nuclear policy;
- How the company is positioning itself to grow within the medical end market;
- What he has learned from Mirion Chairman Larry Kingsley, who achieved tremendous success as CEO of IDEX and Pall Corp.;
- The elements of the business model that lead to sticky, recurring revenue; and
- How the company hopes to achieve its mid-single-digit growth algorithm
*For full disclosure, Cove Street is NOT an MIR shareholder.
Please enjoy the interview at the following sites:
YouTube: https://youtu.be/kodKvMAu4Kg
Spotify: https://open.spotify.com/episode/1d7LqdH3UUqeNLrvOUNgit
Apple: https://podcasts.apple.com/us/podcast/joining-the-ranks-of-the-great/id1579124518?i=1000556388336
Podbean: https://compounders.podbean.com/e/joining-the-ranks-of-the-great-industrial-technology-companies-with-tom-logan-ceo-of-mirion-technologies-inc-nyse-mir/
As always, if you have any comments, feedback, or guest recommendations, please contact us at podcast@covestreetcapital.com. You can also follow the podcast on Twitter @ https://twitter.com/CompoundersPod.
If you missed our last Compounders episode with WildBrain CEO and Vice Chairman Eric Ellenbogen, you can view it here.
Compounders is sponsored by Tegus. With Tegus, you can learn everything you’d want to know about a company on an on-demand digital platform. Investors share their expert calls, allowing others to instantly access more than 25,000 calls on former Compounders guests such as Viasat, Element Solutions, Avid Technology—or almost any company of interest. All you have to do is log in. If you’re ready to go deeper on any company and you appreciate the value of primary research, head to tegus.co/compounders for a free trial.
